Cerity Partners
CLX icon

Cerity Partners’s Clorox CLX Stock Holding History

Cerity Partners’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.01M Sell
73,463
-29,964
-29% -$2.88M 0.01% 944
2026
Q1 		$10.7M Buy
103,427
+9,176
+10% +$1.04M 0.02% 657
2025
Q4 		$9.5M Buy
94,251
+39,936
+74% +$4.34M 0.01% 660
2025
Q3 		$6.7M Sell
54,315
-1,648
-3% -$205K 0.01% 744
2025
Q2 		$6.72M Sell
55,963
-7,536
-12% -$1.01M 0.01% 689
2025
Q1 		$9.35M Buy
63,499
+7,451
+13% +$1.14M 0.02% 509
2024
Q4 		$9.1M Buy
56,048
+3,594
+7% +$588K 0.02% 508
2024
Q3 		$8.55M Buy
52,454
+6,232
+13% +$923K 0.02% 535
2024
Q2 		$6.31M Buy
46,222
+2,963
+7% +$411K 0.02% 542
2024
Q1 		$6.58M Buy
43,259
+5,108
+13% +$762K 0.02% 569
2023
Q4 		$5.44M Sell
38,151
-3,712
-9% -$495K 0.02% 522
2023
Q3 		$5.49M Sell
41,863
-2,384
-5% -$362K 0.03% 400
2023
Q2 		$7.04M Buy
44,247
+2,292
+5% +$370K 0.03% 425
2023
Q1 		$7.07M Buy
41,955
+9,294
+28% +$1.39M 0.02% 426
2022
Q4 		$4.58M Buy
32,661
+25,762
+373% +$3.66M 0.03% 379
2022
Q3 		$886K Sell
6,899
-463
-6% -$66.8K 0.01% 543
2022
Q2 		$1.04M Buy
7,362
+4,799
+187% +$686K 0.01% 540
2022
Q1 		$356K Buy
2,563
+608
+31% +$93.2K 0.01% 679
2021
Q4 		$340K Buy
+1,955
New +$326K 0.01% 729
2021
Q3 		– Sell
-1,252
Closed -$225K – 694
2021
Q2 		$225K Sell
1,252
-3
-0.2% -$548 ﹤0.01% 653
2021
Q1 		$242K Buy
+1,255
New +$242K 0.01% 610

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cerity Partners's CLX Position: Q2 2026 in Review

Cerity Partners reduced its Clorox (CLX) stake by 29% in Q2 2026, selling an estimated $2.88M and leaving 73,463 shares worth $7.01M. The position accounts for 0.01% of the portfolio, ranked #944.

Cerity Partners first reported a position in CLX in Q1 2021 and has held it in 21 quarters since. The position peaked at $10.7M in Q1 2026. 1,055 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Cerity Partners held 73,463 shares of Clorox worth $7.01M as of Q2 2026.
  • Cerity Partners sold 29,964 Clorox shares in Q2 2026, an estimated $2.88M.
  • Clorox made up 0.01% of Cerity Partners's portfolio in Q2 2026, its #944 holding.
  • Cerity Partners first reported a position in Clorox in Q1 2021 and has held it in 21 quarters since.
  • Cerity Partners's Clorox position peaked at $10.7M in Q1 2026.
  • 1,055 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.